Stability in patient care trajectory after discharge to end of life maintained
the ONA take:
Little known about patients’ care after discharge or transfer from inpatient care to another care setting. A recent study focused on the care trajectory of patients after discharge from a German inpatient palliative care unit (PCU) or transfer to other care settings (ie, inpatient hospice, nursing home, or private home).
The prospective observational study surveyed the participants’ central care provider (ie, inpatient hospice, nursing home, or general practitioner) about participants’ care trajectory and hospital readmissions in four weekly follow-up phone calls until the patients’ death.
Of the 467 inpatients from the PCU and 554 inpatients from the PCMT who were treated during the study period, 245 agreed to participate, most of whom were either discharged home, to inpatient hospices, or to nursing homes. More than half of them stayed continuously in their discharge setting, with the remaining participants experiencing some changes of care setting.
The most frequent change was from private home to hospital and from hospital back to private home. Mean overall survival was 51.7 days, and most patients died in their private homes, inpatient hospices, or inpatient PCUs.
These study results show that well-considered discharge planning and an adequate network of care providers can achieve a high percentage of stable care trajectories at the end of life with few or no changes of care setting.
Well-considered discharge planning and an adequate network of care providers can achieve a high percentage of stable care trajectories.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|